Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Stoeck

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
ACS Medicinal Chemistry Letters|October 16, 2020
De-risking Drug Discovery of Intracellular Targeting Peptides: Screening Strategies to Eliminate False-Positive HitsSimon Ng, Yu-Chi Juang, Arun Chandramohan, et al.
Cancer Discovery|August 9, 2014
Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinomaAlexander Stoeck, Serguei Lejnine, Andrew Truong, et al.
Journal of Medicinal Chemistry|June 26, 2024
Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRAS<sup>G12C</sup> InhibitorXiaoshen Ma, David L Sloman, Ruchia Duggal, et al.
Plos One|July 5, 2013
Gauging NOTCH1 Activation in Cancer Using ImmunohistochemistryMichael J Kluk, Todd Ashworth, Hongfang Wang, et al.
Journal of Medicinal Chemistry|April 9, 2026
From KRAS<sup><i>G12D</i></sup> to Pan-KRAS Inhibitors─A Journey Enabled by Synthetic Innovation and Structure-Based Drug DesignXiaoshen Ma, David L Sloman, Timothy J Henderson, et al.
Chemical Science|January 13, 2022
Discovery of cell active macrocyclic peptides with on-target inhibition of KRAS signalingShuhui Lim, Nicolas Boyer, Nicole Boo, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
ACS Medicinal Chemistry Letters|October 16, 2020
De-risking Drug Discovery of Intracellular Targeting Peptides: Screening Strategies to Eliminate False-Positive HitsSimon Ng, Yu-Chi Juang, Arun Chandramohan, et al.
Cancer Discovery|August 9, 2014
Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinomaAlexander Stoeck, Serguei Lejnine, Andrew Truong, et al.
Journal of Medicinal Chemistry|June 26, 2024
Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRAS<sup>G12C</sup> InhibitorXiaoshen Ma, David L Sloman, Ruchia Duggal, et al.
Plos One|July 5, 2013
Gauging NOTCH1 Activation in Cancer Using ImmunohistochemistryMichael J Kluk, Todd Ashworth, Hongfang Wang, et al.
Journal of Medicinal Chemistry|April 9, 2026
From KRAS<sup><i>G12D</i></sup> to Pan-KRAS Inhibitors─A Journey Enabled by Synthetic Innovation and Structure-Based Drug DesignXiaoshen Ma, David L Sloman, Timothy J Henderson, et al.
Chemical Science|January 13, 2022
Discovery of cell active macrocyclic peptides with on-target inhibition of KRAS signalingShuhui Lim, Nicolas Boyer, Nicole Boo, et al.
Pageof 3